View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Cetuximab 250 / Radiation, Head and Neck Tumors, Cycle 2+
Protocol-ID: 1195 V1.1 (Mini), CETU250/Radiation, Head and Neck Tumors, C2+Indication(s)
- Head and Neck Tumors (Squamous Cell); ICD-10 C76.0
ST Radiotherapy: simultaneous Radiation |
| Irradiation was given in 3 different regimens: 5 irradiations per week at 2 Gy, up to a total dose of 70 Gy over 7 weeks. OR 10 irradiations per week with 1.2 Gy, up to a total dose of 72-76.8 Gy over 6-6.5 weeks OR concomitant boost, see study protocol |
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 28.01.2020